Veteran investor Ramesh Damani sees immense opportunities in pharmaceuticals, infrastructure, and domestic manufacturing, despite global uncertainties. He highlights the significant GLP-1 drug market beyond just manufacturers, and advocates for equities over gold for long-term wealth creation. Damani believes India's structural growth story remains strong, urging investors to stay put and focus on quality businesses.